We are on a mission to improve patient care with regenerative biomaterials that are inspired by nature.

Vascudyne™


Developing, manufacturing and commercializing regenerative acellular in-vitro grown “allograft” tissue.

TRUE to Nature™ Biomaterials

Discover the benefits of using 100% biological soft tissue implants and how the investigational TRUE™ Tissue technology is poised to revolutionize healthcare.

Announcing First in Human Use of TRUE™ Graft for Hemodialysis

PRECLINICAL PERFORMANCE

Non-immunogenic
Non-calcific
Cellular infiltration and tissue regeneration
No evidence of thrombosis or intimal hyperplasia

Successful 6-month AV graft study in baboons

BIOLOGICAL

Acellular
Ready to use, off-the shelf allograft

Naturally derived extracellular matrix

No crosslinking or other chemical fixation
No synthetic materials used through entire manufacturing process

Mechanical

Resembles and feels like natural tissue

High burst strength on par with native arteries

Predictable and tunable anisotropic tensile properties

High suture retention, capable of sewing into valve frames

Excellent post-implantation flow profiles of AV grafts in First in Human clinical study

News

Vascudyne announces successful First Human Use of TRUE™ Vascular Graft for hemodialysis access

Vascudyne’s CSO presents at the Heart Valve Society Meeting on tissue remodeling of engineered valved conduit evaluated at 52 weeks in the growing lamb

Lab-created heart valves can grow with the recipient article published in Science Translational Medicine

Proud Member of:

7 + 15 =

Copyright 2021 | Vascudyne, Inc.